Begoña Martin-Castillo

Nom:
Begoña Martin
Firma: Begoña Martin-Castillo
Posició:
Col·laboradors

"Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity. "

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab.

Subscriure a Begoña Martin-Castillo